Literature DB >> 8572711

Longitudinal studies of Giardia contamination in two community drinking water supplies: cyst levels, parasite viability, and health impact.

J Isaac-Renton1, W Moorehead, A Ross.   

Abstract

Giardia cyst concentrations were determined in an inventory of 153 raw and 91 chlorinated drinking water samples collected at 86 sites from throughout the western Canadian province of British Columbia. Sixty-four percent of raw water samples were cyst positive (69% of sites). Cyst concentrations were lower in chlorinated than in raw water. The viability of cysts in drinking water samples assessed by infectivity in Mongolian gerbils (Meriones unguiculatus) was decreased in chlorinated water. Two rural communities using Giardia-contaminated surface drinking water sources were selected for longitudinal studies including drinking water testing and serological studies of residents. Three hundred thirty-six raw and treated samples from these communities were collected over 24 months. Cyst concentrations and viability were assessed in a 12-month study of each community. Parasite concentrations were lower in chlorinated water than in raw water in both communities. Cyst concentrations were lower in reservoir-settled water than in raw water. Viability, assessed by animal infectivity and corrected for inoculum, decreased following reservoir settling as well as after chlorination. A bolus or spiking phenomenon of cysts was observed in both community drinking water systems and deserves further study. A striking seasonal pattern was seen in one community but not in the second. The seroprevalence data and number of laboratory-confirmed cases identified in each year-long community study are consistent with the possibility that low-level endemic transmission is occurring.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8572711      PMCID: PMC167771          DOI: 10.1128/aem.62.1.47-54.1996

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  7 in total

1.  Propidium iodide as an indicator of Giardia cyst viability.

Authors:  J F Sauch; D Flanigan; M L Galvin; D Berman; W Jakubowski
Journal:  Appl Environ Microbiol       Date:  1991-11       Impact factor: 4.792

2.  Epidemiology of giardiasis in Wisconsin: increasing incidence of reported cases and unexplained seasonal trends.

Authors:  D G Addiss; J P Davis; J M Roberts; E E Mast
Journal:  Am J Trop Med Hyg       Date:  1992-07       Impact factor: 2.345

3.  Comparison of an in vitro method and an in vivo method of Giardia excystation.

Authors:  J L Isaac-Renton; H Shahriari; W R Bowie
Journal:  Appl Environ Microbiol       Date:  1992-05       Impact factor: 4.792

4.  Risk assessment and control of waterborne giardiasis.

Authors:  J B Rose; C N Haas; S Regli
Journal:  Am J Public Health       Date:  1991-06       Impact factor: 9.308

5.  Giardia lamblia infections in Mongolian gerbils: an animal model.

Authors:  M Belosevic; G M Faubert; J D MacLean; C Law; N A Croll
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

6.  Waterborne giardiasis at a mountain resort: evidence for acquired immunity.

Authors:  G R Istre; T S Dunlop; G B Gaspard; R S Hopkins
Journal:  Am J Public Health       Date:  1984-06       Impact factor: 9.308

7.  Occurrence of Giardia and Cryptosporidium spp. in surface water supplies.

Authors:  M W LeChevallier; W D Norton; R G Lee
Journal:  Appl Environ Microbiol       Date:  1991-09       Impact factor: 4.792

  7 in total
  12 in total

1.  Use of passive surveillance data to study temporal and spatial variation in the incidence of giardiasis and cryptosporidiosis.

Authors:  E N Naumova; J T Chen; J K Griffiths; B T Matyas; S A Estes-Smargiassi; R D Morris
Journal:  Public Health Rep       Date:  2000 Sep-Oct       Impact factor: 2.792

2.  Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.

Authors:  Jeffrey W Priest; Delynn M Moss; Govinda S Visvesvara; Cara C Jones; Anna Li; Judith L Isaac-Renton
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

3.  A high-efficiency microfluidic device for size-selective trapping and sorting.

Authors:  Jinho Kim; Jessey Erath; Ana Rodriguez; Changhuei Yang
Journal:  Lab Chip       Date:  2014-07-21       Impact factor: 6.799

4.  An Italian study on Cryptosporidium and Giardia in wastewater, fresh water and treated water.

Authors:  Rossella Briancesco; Lucia Bonadonna
Journal:  Environ Monit Assess       Date:  2005-05       Impact factor: 2.513

Review 5.  Zoonotic diseases in Canada: an interdisciplinary challenge.

Authors:  J Hamilton
Journal:  CMAJ       Date:  1996-08-15       Impact factor: 8.262

6.  Studies of Giardia spp. and Cryptosporidium spp. in two adjacent watersheds.

Authors:  C Ong; W Moorehead; A Ross; J Isaac-Renton
Journal:  Appl Environ Microbiol       Date:  1996-08       Impact factor: 4.792

7.  Occurrence and potential health risk of Cryptosporidium and Giardia in different water catchments in Belgium.

Authors:  Amimul Ehsan; Thomas Geurden; Stijn Casaert; Jef Paulussen; Lut De Coster; Toon Schoemaker; Rachel Chalmers; Grietje Grit; Jozef Vercruysse; Edwin Claerebout
Journal:  Environ Monit Assess       Date:  2015-01-24       Impact factor: 2.513

8.  Giardia cysts in wastewater treatment plants in Italy.

Authors:  Simone M Cacciò; Marzia De Giacomo; Francesca A Aulicino; Edoardo Pozio
Journal:  Appl Environ Microbiol       Date:  2003-06       Impact factor: 4.792

9.  Real-time PCR for quantification of Giardia and Cryptosporidium in environmental water samples and sewage.

Authors:  Rebecca A Guy; Pierre Payment; Ulrich J Krull; Paul A Horgen
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

10.  Geographical and temporal distribution of human giardiasis in Ontario, Canada.

Authors:  Agricola Odoi; S Wayne Martin; Pascal Michel; John Holt; Dean Middleton; Jeff Wilson
Journal:  Int J Health Geogr       Date:  2003-08-11       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.